Enhanced Tau Aggregation in the Presence of Amyloid β

The American Journal of Pathology
Rachel E BennettBradley T Hyman

Abstract

Amyloid plaques and neurofibrillary tangles co-occur in Alzheimer disease, but with different topological and temporal patterns. Whether these two lesions are independent or pathobiologically related is uncertain. For example, amyloid deposition in the neocortex precedes the spread of tau neurofibrillary tangles from the limbic areas to the cortex. We examined the aggregation properties of tau isolated from human cases with early tau pathology (Braak II) with and without plaques. Using a well-established HEK cell biosensor assay, we show that tau from cases with plaques has an enhanced ability to induce tau aggregates compared to tau from cases without plaques. To further explore this effect, we combined mice carrying the APP/PS1 transgene array that develop plaques with rTg4510 mice carrying the P301L mutant human tau transgene that develop extensive tau pathology with age. The resulting APP/PS1-rTg4510 mice had a threefold increase in tau seeding activity over the rTg4510 strain, without change in tau production or extracellular release. Surprisingly, this effect was observed before overt amyloid deposition. The enhancement of tau aggregation was also apparent by an increase in histological measures of tau pathology in young ...Continue Reading

Citations

Jan 23, 2019·Brain : a Journal of Neurology·Jong-Chan ParkInhee Mook-Jung
Jan 24, 2018·Proceedings of the National Academy of Sciences of the United States of America·Rachel E BennettBradley T Hyman
Dec 24, 2019·Neuropathology and Applied Neurobiology·Z Jaunmuktane, S Brandner
Nov 11, 2019·Acta Neuropathologica Communications·Maria Calvo-RodriguezBrian J Bacskai
May 28, 2020·Nature Communications·Jacob W VogelUNKNOWN Swedish BioFinder Study
Jul 10, 2020·Neuropathology and Applied Neurobiology·D Boche, J A R Nicoll
Aug 18, 2020·Emerging Topics in Life Sciences·Jacob I AyersStanley B Prusiner
Jul 22, 2017·Frontiers in Aging Neuroscience·Ana I RamirezJosé M Ramírez
May 2, 2018·Journal of Alzheimer's Disease : JAD·Yacoubou Abdoul Razak MahamanXiaochuan Wang
Jun 27, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Qiuchen ZhengNoel D Lazo
Jan 2, 2019·Acta Neuropathologica·Cristina VergaraJean-Pierre Brion
Jun 24, 2020·Nature Medicine·Simon DujardinBradley T Hyman
Aug 3, 2020·Journal of Neural Transmission·Kurt A Jellinger
Feb 23, 2018·Frontiers in Neuroscience·Rudimar L FrozzaFernanda G De Felice
May 3, 2019·Science Translational Medicine·Atsushi AoyagiStanley B Prusiner
Jul 18, 2018·Journal of Neuropathology and Experimental Neurology·Hsin-Yi WuHwan-Ching Tai
Dec 19, 2018·Nature Neuroscience·Marc Aurel BuscheBradley T Hyman
Mar 20, 2019·Journal of Pathology and Translational Medicine·Daru KimJae-Hyuk Lee
Nov 19, 2019·Frontiers in Aging Neuroscience·Puneet TalwarRachna Agarwal
Aug 12, 2020·Nature Neuroscience·Marc Aurel Busche, Bradley T Hyman
Sep 29, 2020·Frontiers in Cellular Neuroscience·Alfred Kihoon LeeHideto Takahashi
Dec 4, 2019·Frontiers in Molecular Neuroscience·Woo Shik ShinLin Jiang
May 28, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Lidia CicconeNicolo Tonali
Aug 23, 2020·International Journal of Molecular Sciences·Md Sahab UddinMohamed M Abdel-Daim
Feb 14, 2020·Brain Communications·Alexandra J WeigandUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
May 8, 2018·Brain : a Journal of Neurology·Sarah L DeVosBradley T Hyman
Aug 20, 2020·Acta Neuropathologica Communications·Rachel E BennettBradley T Hyman
Oct 23, 2020·The Journal of Experimental Medicine·Fares BassilVirginia M-Y Lee
Jun 2, 2020·CNS & Neurological Disorders Drug Targets·Veronique RibanMarc Verleye
Nov 19, 2019·Biological Psychiatry·Thomas VogelsMichael Schöll
Jan 31, 2020·Neuroscience and Biobehavioral Reviews·Brendan B McAllisterMajid H Mohajerani
Jan 19, 2021·The FEBS Journal·Katerina KonstantouleaJoost Schymkowitz
Oct 14, 2020·PLoS Computational Biology·Travis B ThompsonUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Nov 19, 2020·Brain Sciences·Antonio Dominguez-MeijideTiago Fleming Outeiro

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.